Glucose detection in fabry-perot etalons

Details

Event

2009-01-24

Speakers

Event

Glucose detection in fabry-perot etalons

Current continuous glucose measurement (CGM) detectors have inherent limitations that constrain their implant longevity and their accuracy at low glucose concentrations. Foremost, their electrochemical detection-enzyme is consumed during use and creates toxic byproducts that initiate a rejection response. We propose a new CGM approach that is appropriate for a miniaturized subcutaneous CGM implant with an extended lifetime. It relies on the differential determination of the reflective index in a double chamber etalon. By the use of appropriate filtering we achieved glucose specificity and good sensitivity even at low glucose concentrations, as well as intrinsic temperature, light intensity and alignment compensation.

Additional information

Focus Areas

Our work is centered around a series of Focus Areas that we believe are the future of science and technology.

FIND OUT MORE
Licensing & Commercialization Opportunities

We’re continually developing new technologies, many of which are available for Commercialization.

FIND OUT MORE
News

PARC scientists and staffers are active members and contributors to the science and technology communities.

FIND OUT MORE